Navigation Links
Novavax CEO to Present at Piper Jaffray 20th Annual Healthcare Conference
Date:12/1/2008

ROCKVILLE, Md., Dec. 1 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced today that Dr. Rahul Singhvi, President and Chief Executive Officer, will be presenting at the Piper Jaffray 20th Annual Healthcare Conference at 11:00 a.m. (EST) on December 2, 2008 in New York. Dr. Singhvi will provide an overview of the company's strategy, research and development progress. A link to the live presentation can be accessed via the Company website at http://www.novavax.com under the Investor/Events. An archive of the presentation will be available one hour after the event on the Novavax website for 90 days.

ABOUT NOVAVAX

Novavax, Inc. (Nasdaq: NVAX) is a clinical stage biotechnology company, creating novel vaccines to address a broad range of infectious diseases worldwide using advanced proprietary virus-like particle (VLP) technology. The Company produces these VLP based, potent, recombinant vaccines utilizing new and efficient manufacturing approaches. Additional information about Novavax is available at http://www.novavax.com and in the Company's various filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Novavax, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Novavax CEO to Present at Lazard Capital Markets 5th Annual Healthcare Conference
2. Novavax Announces Release Date of 2008 Third Quarter Financial Results and Investor Conference Call
3. Novavax CEO to Present at Oppenheimer 19th Annual Healthcare Conference
4. Novavax CEO to Present at BIO Investor Forum 2008
5. Novavax Completes Enrollment of Its Seasonal Influenza VLP Vaccine Phase IIa Clinical Trial
6. Novavax Commences Clinical Testing of its Seasonal Influenza VLP Vaccine Candidate
7. Novavax Announces Closing of $18 Million Registered Direct Offering
8. Novavax Announces Pricing of $18 Million Financing of Common Stock and Warrants
9. Novavax to Join Russell 3000 Index
10. Novavax CEO to Present at Piper Jaffray Europe Conference, London, UK
11. Novavax CEO to Present at FBR Capital Markets 12th Annual Spring Investor Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... Four of the top 10 pharma...rid eCTD submissions to Health Canada. Datafarm&rs...’s 7th Canadian DIA Annual Meeting where Hea...nsor companies may submit Hybrid eCTD regulatory s...ons with no prior permission request. , ...
(Date:11/8/2009)..., MOUNTAIN VIEW, Calif. Nov. 5, 2009 Compl...encing company, today announced publication of a r...rietary DNA sequencing platform, including analysi...es. The consumables cost for these three genomes s...oarrays ranged from $8,005 for 87x coverage to $1,...
(Date:11/6/2009)..., AURORA, Ontario, Nov. 6 /PRNewswire-FirstCall... Sheets: HXBPF) today announced that John Docherty...ent at Merriman Curhan Ford,s 6th annual Investor ...tel Hotel in New York City. Mr. Docherty will pro...development programs L-DOS47 and Topical Interfero...
(Date:11/6/2009)..., SPRING VALLEY, Calif., Nov. 6 ... awarded a Small Business Innovative Research (SBI...rch and Material command. Under terms of the agree...gents (ASRs) for the diagnosis of Dengue virus. ...that represents a major threat to military forces ...
Breaking Biology Technology:Datafarm Responds to Health Canada's Announcement of Hybrid eCTD Submission Procedural Simplification 2Complete Genomics publishes in Science on low-cost sequencing of 3 human genomes 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 2Helix BioPharma to Present at Merriman Curhan Ford's Investor Summit 2009 on November 10th 3Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus 2
... Biosciences announces,an enhanced matching funds ...n in genomics. $1.75 million in matching funds is ... to each qualifying institution. The,Genomics Educ... streamlined,application process to help colleges ...ndergraduate students studying molecular biology a...
...n combats an,alarming rise in chronic diseases, th...rica (PhRMA) today released a new report on the ne...hat offer hope to millions,of patients., The repo...d,biotechnology companies - including several loca...tech medicines., Today,s report was released in M...
...ble Oils has reached a,key milestone in its effort...tunities for Montana farmers. The company received... a department of the Federal Drug,Administration, ...ot beef,cattle and growing swine up to 2 percent o... a by-product of camelina oil extraction., Sustai...
Other Biology Technology:New Report on 633 Biotechnology Medicines Under Development Released in Michigan 2New Report on 633 Biotechnology Medicines Under Development Released in Michigan 3Sustainable Oils Receives Regulatory Approval for Feeding Camelina Meal in Livestock Diets 2Sustainable Oils Receives Regulatory Approval for Feeding Camelina Meal in Livestock Diets 3
(Date:11/8/2009)... Ind. - Researchers at Purdue University have disc...fibers in spinal cord injuries using nano-spheres ...r an accident. , The synthetic "copolymer micell...in diameter, or roughly 100 times smaller than the...e been studying how to deliver drugs for cancer tr...
(Date:11/6/2009)...ration is now open for the Society of Intervention...gy (IO) Therapies" Webinar, which will provide the...treatment of liver tumors, kidney tumor ablation a...tion of physicians, scientists and allied health p...through pioneering advances in image-guided therap...
(Date:11/6/2009)...6 Auburn Hills, MI-based Law Enfor...talling its locker system and patent-pending Biome...Department of Health and Human Services, National ... The locker system will support the NIH,s entire p... nation,s medical research agency. The project is...
Breaking Biology News(10 mins):Findings show nanomedicine promising for treating spinal cord injuries 2Findings show nanomedicine promising for treating spinal cord injuries 3Society of Interventional Radiology hosts oncology therapies Webinar, offers resources 2EPA grant to University of Chicago for research on food allergy triggers 9332 1Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi3 Clinical Trial of R788 in Rheumatoid Arthritis 52567 1Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi3 Clinical Trial of R788 in Rheumatoid Arthritis 52567 2Study in this Week 26apos 3Bs Issue of Cell Finds Injected Growth Factor Spurs Heart Regeneration 52563 1Study in this Week 26apos 3Bs Issue of Cell Finds Injected Growth Factor Spurs Heart Regeneration 52563 2Study in this Week 26apos 3Bs Issue of Cell Finds Injected Growth Factor Spurs Heart Regeneration 52563 3
...hiny amber jewelry and a mucky Florida swamp have ...m that could be anywhere from 15 million to 130 mi...f Florida and the Museum of Natural History in Ber...quatic critters such as beetles and small crustace...the water from pine-like trees. Their findings are...
...ber 17, 2007. -- It all started as a graduate scho...ire to figure out why things live where they do, s...ive in different places? Ive been studying the dis...ears. So I even made this question the basis of my...s. , That burning desire led Neilson to develop t...
... the leading cause of death due to infectious dise...lion people are currently infected, and although m... occur. This paper by Denise Kirschner and colleag...ducts virtual clinical trials to examine the cause... (TNF) is a protein that facilitates cellcell comm...
Other Biology News:Scientists find how amber becomes death trap for watery creatures 2Scientists find how amber becomes death trap for watery creatures 3Neilson member of Nobel Prize-winning panel of scientists 2
HeLa Cell Slide from ProSci, Inc
EL4 Cell Slide from ProSci, Inc
IHC Select TE Buffer pH 9.0 [Antigen/ Epitope Retrieval Reagent], 10x from CHEMICON
Hep G2 Cell Slide from ProSci, Inc
Biology Products: